Haloperidol Rompharm

Haloperidol Rompharm is a prescription‑only oral medication that contains the active ingredient haloperidol, a butyrophenone‑class antipsychotic. Distributed in the European Union, it is typically supplied as tablets, with strength determined by the prescribing clinician. The product works by blocking dopamine D2 receptors in the brain, helping to manage symptoms of certain psychiatric disorders. It is intended for use under medical supervision and is not available over the counter.

Haloperidol Rompharm is indicated for several psychiatric conditions where dopamine blockade is therapeutic. The medication may be prescribed as part of a comprehensive treatment plan that includes psychosocial interventions.

- Schizophrenia, including acute exacerbations. - Acute psychotic episodes associated with mood disorders. - Tourette syndrome and other tic disorders. - Severe agitation or aggression when rapid control is required. - Adjunctive treatment for hyperkinetic movement disorders. - Maintenance therapy to prevent relapse after stabilization of psychotic symptoms.

Side effects of Haloperidol Rompharm vary in frequency and severity, reflecting its dopamine antagonism.

Common: - Drowsiness or sedation. - Extrapyramidal symptoms such as tremor, rigidity, or akathisia. - Dry mouth and increased salivation. - Constipation or gastrointestinal discomfort.

Serious: - Neuroleptic malignant syndrome, a rare but life‑threatening reaction. - Tardive dyskinesia, characterized by involuntary facial movements. - Significant cardiac arrhythmias, including QT prolongation.

Clinicians should evaluate patient history and monitor for specific risks before and during treatment with Haloperidol Rompharm.

- History of cardiovascular disease or prolonged QT interval. - Pre‑existing movement disorders or Parkinsonian symptoms. - Severe hepatic or renal impairment. - Pregnancy, lactation, or plans for conception. - Elderly patients, especially those with dementia‑related psychosis. - Concomitant use of other central nervous system depressants.

Haloperidol Rompharm can interact with several drug classes, potentially altering its efficacy or safety profile.

Avoid: - Other antipsychotics or dopamine antagonists, which may increase extrapyramidal risk. - Medications that prolong the QT interval, such as certain antiarrhythmics or macrolide antibiotics. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that raise haloperidol plasma levels.

Use with caution: - CNS depressants including benzodiazepines, opioids, or alcohol. - Anticholinergic agents that may mask extrapyramidal symptoms. - CYP2D6 substrates, as haloperidol metabolism may be affected.